Page 672 - Williams Hematology ( PDFDrive )

646 Part VI: The Erythrocyte Chapter 43: Iron Deficiency and Overload 647

123. Bessman JD, Feinstein DI: Quantitative anisocytosis as a discriminant between iron 160. Mei Z, Parvanta I, Cogswell ME, et al: Erythrocyte protoporphyrin or hemoglobin:
deficiency and thalassemia minor. Blood 53(2):288–293, 1979. Which is a better screening test for iron deficiency in children and women? Am J Clin
124. England JM, Ward SM, Down MC: Microcytosis, anisocytosis and the red cell indices Nutr 77(5):1229–1233, 2003.
in iron deficiency. Br J Haematol 34(4):589–597, 1976. 161. Braun J: Erythrocyte zinc protoporphyrin. Kidney Int Suppl 69:S57–S60, 1999.
125. Beutler E: The red cell indices in the diagnosis of iron-deficiency anemia. Ann Intern 162. Hastka J, Lasserre JJ, Schwarzbeck A, et al: Zinc protoporphyrin in anemia of chronic
Med 50(2):313–322, 1959. disorders. Blood 81(5):1200–1204, 1993.
126. Verma V, Ayalew G, Sidhu G, et al: An analysis of the relationship between severe iron 163. Skikne BS, Flowers CH, Cook JD: Serum transferrin receptor: A quantitative measure
deficiency anemia and thrombocytopenia. Ann Hematol 1–3, 2014. of tissue iron deficiency. Blood 75(9):1870–1876, 1990.
127. Dan K: Thrombocytosis in iron deficiency anemia. Intern Med 44(10):1025–1026, 2005. 164. Skikne BS: Serum transferrin receptor. Am J Hematol 83(11):872–875, 2008.
128. Keung YK, Owen J: Iron deficiency and thrombosis: Literature review. Clin Appl 165. Pettersson T, Kivivuori SM, Siimes MA: Is serum transferrin receptor useful for detect-
Thromb Hemost 10(4):387–391, 2004. ing iron-deficiency in anaemic patients with chronic inflammatory diseases? Br J Rheu-
129. Geddis AE, Kaushansky K: Cross-reactivity between erythropoietin and thrombopoie- matol 33(8):740–744, 1994.
tin at the level of Mpl does not account for the thrombocytosis seen in iron deficiency. 166. Thorpe SJ, Heath A, Sharp G, et al: A WHO reference reagent for the Serum Transferrin
J Pediatr Hematol Oncol 25(11):919–920, 2003. Receptor (sTfR): International collaborative study to evaluate a recombinant soluble
130. Kasper CK, Whissell DY, Wallerstein RO: Clinical aspects of iron deficiency. JAMA transferrin receptor preparation. Clin Chem Lab Med 48(6):815–820, 2010.
191:359–363, 1965. 167. Uaprasert N, Rojnuckarin P, Bhokaisawan N, et al: Elevated serum transferrin receptor
131. Barron BA, Hoyer JD, Tefferi A: A bone marrow report of absent stainable iron is not levels in common types of thalassemia heterozygotes in Southeast Asia: A correlation
diagnostic of iron deficiency. Ann Hematol 80(3):166–169, 2001. with genotypes and red cell indices. Clin Chim Acta 403(1–2):110–113, 2009.
132. Thomason RW, Lavelle J, Nelson D, et al: Parenteral iron therapy is associated with 168. Mockenhaupt FP, May J, Stark K, et al: Serum transferrin receptor levels are increased in
a characteristic pattern of iron staining on bone marrow aspirate smears. Am J Clin asymptomatic and mild Plasmodium falciparum-infection. Haematologica 84(10):869–
Pathol 128(4):590–593, 2007. 873, 1999.
133. Cavill IA: Iron status indicators: Hello new, goodbye old? Blood 101(1):372–373, 2003. 169. Cook JD, Flowers CH, Skikne BS: The quantitative assessment of body iron. Blood
134. Ellis LD, Jensen WN, Westerman MP: Marrow iron. An evaluation of depleted stores in 101(9):3359–3363, 2003.
a series of 1,332 needle biopsies. Ann Intern Med 61:44–49, 1964. 170. Skikne BS, Punnonen K, Caldron PH, et al: Improved differential diagnosis of anemia
135. Garby L, Irnell L, Werner I: Iron deficiency in women of fertile age in a Swedish com- of chronic disease and iron deficiency anemia: A prospective multicenter evaluation
munity. II. Efficiency of several laboratory tests to predict the response to iron supple- of soluble transferrin receptor and the sTfR/log ferritin index. Am J Hematol 86(11):
mentation. Acta Med Scand 185(1–2):107–111, 1969. 923–927, 2011.
136. Dale JC, Burritt MF, Zinsmeister AR: Diurnal variation of serum iron, iron-binding 171. Suominen P, Punnonen K, Rajamaki A, et al: Serum transferrin receptor and transfer-
capacity, transferrin saturation, and ferritin levels. Am J Clin Pathol 117(5):802–808, rin receptor-ferritin index identify healthy subjects with subclinical iron deficits. Blood
2002. 92(8):2934–2939, 1998.
137. Mardell M, Zilva JF: Effect of oral contraceptives on the variations in serum-iron dur- 172. Punnonen K, Irjala K, Rajamaki A: Serum transferrin receptor and its ratio to serum
ing the menstrual cycle. Lancet 2(7530):1323–1325, 1967. ferritin in the diagnosis of iron deficiency. Blood 89(3):1052–1057, 1997.
138. Zilva JF, Patston VJ: Variations in serum-iron in healthy women. Lancet 1(7435):459– 173. Brugnara C, Mohandas N: Red cell indices in classification and treatment of anemias:
462, 1966. From M. M. Wintrobes’s original 1934 classification to the third millennium. Curr Opin
139. Cartwright GE: The anemia of chronic disorders. Semin Hematol 3(4):351–375, 1966. Hematol 20(3):222–230, 2013.
140. Adamson JW: The anemia of inflammation/malignancy: Mechanisms and manage- 174. Brugnara C, Schiller B, Moran J: Reticulocyte hemoglobin equivalent (Ret He) and
ment. Hematology Am Soc Hematol Educ Program 159–165, 2008. assessment of iron-deficient states. Clin Lab Haematol 28(5):303–308, 2006.
141. Huang CH, Chang CC, Kuo CL, et al: Serum iron concentration, but not hemoglobin, 175. Bovy C, Gothot A, Krzesinski JM, et al: Mature erythrocyte indices: New markers of
correlates with TIMI risk score and 6-month left ventricular performance after primary iron availability. Haematologica 90(4):549–551, 2005.
angioplasty for acute myocardial infarction. PLoS One 9(8):e104495, 2014. 176. Iolascon A, De FL, Beaumont C: Molecular basis of inherited microcytic anemia due to
142. Syrkis I, Machtey I: Hypoferremia in acute myocardial infarction. J Am Geriatr Soc defects in iron acquisition or heme synthesis. Haematologica 94(3):395–408, 2009.
21(1):28–30, 1973. 177. Beutler E, West C: Hematologic differences between African-Americans and whites:
143. Follezou JY, Bizon M: Cancer chemotherapy induces a transient increase of serum-iron The roles of iron deficiency and alpha-thalassemia on hemoglobin levels and mean cor-
level. Neoplasma 33(2):225–231, 1986. puscular volume. Blood 106(2):740–745, 2005.
144. Seligman PA, Schleicher RB: Comparison of methods used to measure serum iron in 178. Fairbanks VF, Oliveros R, Brandabur JH, et al: Homozygous hemoglobin E mimics
the presence of iron gluconate or iron dextran. Clin Chem 45(6 Pt 1):898–901, 1999. beta-thalassemia minor without anemia or hemolysis: Hematologic, functional, and
145. Geisser P, Burckhardt S: The pharmacokinetics and pharmacodynamics of iron prepa- biosynthetic studies of first North American cases. Am J Hematol 8(1):109–121, 1980.
rations. Pharmaceutics 3(1):12–33, 2011. 179. Fairbanks VF, Gilchrist GS, Brimhall B, et al: Hemoglobin E trait reexamined: A cause
146. Cohen LA, Gutierrez L, Weiss A, et al: Serum ferritin is derived primarily from macro- of microcytosis and erythrocytosis. Blood 53(1):109–115, 1979.
phages through a nonclassical secretory pathway. Blood 116(9):1574–1584, 2010. 180. Johnson CS, Tegos C, Beutler E: Thalassemia minor: Routine erythrocyte measure-
147. Lipschitz DA, Cook JD, Finch CA: A clinical evaluation of serum ferritin as an index of ments and differentiation from iron deficiency. Am J Clin Pathol 80(1):31–36, 1983.
iron stores. N Engl J Med 290(22):1213–1216, 1974. 181. Duma H, Efremov G, Sadikario A, et al: Study of nine families with haemoglobin-
148. Sears DA: Anemia of chronic disease. Med Clin North Am 76(3):567–579, 1992. Lepore. Br J Haematol 15(2):161–172, 1968.
149. Hansen TM, Hansen NE: Serum ferritin as indicator of iron responsive anaemia in 182. Cartei G, Chisesi T, Cazzavillan M, et al: Relationship between Hb and HbA2 concen-
patients with rheumatoid arthritis. Ann Rheum Dis 45(7):596–602, 1986. trations in beta-thalassemia trait and effect of iron deficiency anaemia. Biomedicine
150. Fishbane S, Kalantar-Zadeh K, Nissenson AR: Serum ferritin in chronic kidney disease: (Taipei) 25(8):282–284, 1976.
Reconsidering the upper limit for iron treatment. Semin Dial 17(5):336–341, 2004. 183. Infusino I, Braga F, Dolci A, et al: Soluble transferrin receptor (sTfR) and sTfR/log
151. Milman N, Graudal N, HegnhØj J, et al: Relationships among serum iron status mark- ferritin index for the diagnosis of iron-deficiency anemia. A meta-analysis. Am J Clin
ers, chemical and histochemical liver iron content in 117 patients with alcoholic and Pathol 138(5):642–649, 2012.
non-alcoholic hepatic disease. Hepatogastroenterology 41(1):20–24, 1994. 184. Bregman DB, Morris D, Koch TA, et al: Hepcidin levels predict nonresponsiveness to
152. Milman N, Graudal N: Serum ferritin in acute viral hepatitis. Scand J Gastroenterol oral iron therapy in patients with iron deficiency anemia. Am J Hematol 88(2):97–101,
19(1):38–40, 1984. 2013.
153. Matzner Y, Konijn AM, Hershko C: Serum ferritin in hematologic malignancies. Am J 185. Prentice AM, Doherty CP, Abrams SA, et al: Hepcidin is the major predictor of erythro-
Hematol 9(1):13–22, 1980. cyte iron incorporation in anemic African children. Blood 119(8):1922–1928, 2012.
154. Medrano-Engay B, Irun P, Gervas-Arruga J, et al: Iron homeostasis and infIamma- 186. Intragumtornchai T, Rojnukkarin P, Swasdikul D, et al: The role of serum ferritin in
tory biomarker analysis in patients with type 1 Gaucher disease. Blood Cells Mol Dis the diagnosis of iron deficiency anaemia in patients with liver cirrhosis. J Intern Med
53(4):171–175, 2014. 243(3):233–241, 1998.
155. Mekinian A, Stirnemann J, Belmatoug N, et al: Ferritinemia during type 1 Gaucher dis- 187. Prieto J, Barry M, Sherlock S: Serum ferritin in patients with iron overload and with
ease: Mechanisms and progression under treatment. Blood Cells Mol Dis 49(1):53–57, acute and chronic liver diseases. Gastroenterology 68(3):525–533, 1975.
2012. 188. Macdougall IC, Hutton RD, Cavill I, et al: Poor response to treatment of renal anaemia
156. Moore C Jr, Ormseth M, Fuchs H: Causes and significance of markedly elevated serum with erythropoietin corrected by iron given intravenously. BMJ 299(6692):157–158,
ferritin levels in an academic medical center. J Clin Rheumatol 19(6):324–328, 2013. 1989.
157. Lehmberg K, McClain KL, Janka GE, Allen CE: Determination of an appropriate cut- 189. Dukkipati R and Kalantar-Zadeh K. Should we limit the ferritin upper threshold to 500
off value for ferritin in the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr ng/mL in CKD patients? Nephrol News Issues 21(1):34–38, 2007.
Blood Cancer 61(11):2101–2103, 2014. 190. Macdougall IC, Bock AH, Carrera F, et al: FIND-CKD: A randomized trial of intrave-
158. Mayr R, Janecke AR, Schranz M, et al: Ferroportin disease: A systematic meta-analysis nous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and
of clinical and molecular findings. J Hepatol 53(5):941–949, 2010. iron deficiency anaemia. Nephrol Dial Transplant 29(11):2075–2084, 2014.
159. Magge H, Sprinz P, Adams WG, et al: Zinc protoporphyrin and iron deficiency screen- 191. Chung M, Chan JA, Moorthy D, et al: Biomarkers for Assessing and Managing Iron Defi-
ing: Trends and therapeutic response in an urban pediatric center. JAMA Pediatr ciency Anemia in Late-Stage Chronic Kidney Disease: Future Research Needs: Identifica-
167(4):361–367, 2013. tion of Future Research Needs from Comparative Effectiveness Reviews, No. 83 [Internet].

Kaushansky_chapter 43_p0627-0650.indd 647 9/17/15 6:27 PM